Documentation scienceplus.abes.fr version Bêta

À propos de : Trials of antihypertensive treatment—new agenda for the millennium        

AttributsValeurs
type
Is Part Of
Subject
Title
  • Trials of antihypertensive treatment—new agenda for the millennium
has manifestation of work
related by
Author
Abstract
  • In 1968 a group of investigators from the US Veterans Association study reported that, compared to placebo, antihypertensive medication dramatically reduces morbidity and mortality in patients whose diastolic blood pressure was 115 mm Hg or higher. Three years later a reduction of morbidity had also been demonstrated in subjects whose diastolic pressure ranged from 95 to 114 mm Hg. In the following decades these findings were confirmed in numerous investigations of various populations. We now know that antihypertensive treatment is beneficial in mild hypertension, in isolated systolic hypertension, and in hypertension of the elderly. When it comes to the treatment of mild hypertension we will have to practice evidenceless medicine and act on the internal logic of the issue. The logic suggests that many present-day antihypertensive agents are harmless, that over the long term they may prevent target organ damage, that early intervention may be more beneficial than late treatment, and, finally, that treating mild hypertension may have a major positive impact on public health.
article type
is part of this journal



Alternative Linked Data Documents: ODE     Content Formats:       RDF       ODATA       Microdata